A Single Arm Open Clinical Trial to Evaluate the Combined Effect of Guggulu Tiktaka Ghrita Capsule and Eranda Taila Pana Along with Isthika Sweda in the Management of Heel Pain

A Single Arm Open Clinical Trial to Evaluate the Combined Effect of Guggulu Tiktaka Ghrita Capsule and Eranda Taila Pana Along with Isthika Sweda in the Management of Vatakantaka with Special Reference to Plantar Fasciitis. - GEI

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107748

Enrollment

Registered

2026-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M709- Unspecified soft tissue disorder related to use, overuse and pressure

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with Lakshanas of Vatakantaka. Patients between age group20 -60years of either sex. Virechana Arha patients

Exclusion criteria

Exclusion criteria: Fractures and traumatic injuries of heel Dislocation of ankle joint. Pregnancy and lactation. Anatomical deformities like pes planus and pes cavus Systemic diseases such as DM

Design outcomes

Primary

Measure	Time frame
Reduction of Pain and Tenderness in Plantar FasciitisTimepoint: 30 Days	—

Secondary

Measure	Time frame
To study the combined effect of Guggulu Tiktaka Ghrita Capsule, and Murchita Eranda Taila Pana along with Isthika Sweda in the management of Vatakantaka with special reference to plantar fasciitis.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDR S S KALYANI

BVVS Ayurved Medical College and Hospital, Bagalkot, Karnataka 587101

drleelakalyani@gmail.com9591273858

Outcome results